Market News & Trends
Impax Laboratories Completes Major Acquisitions
Impax Laboratories, Inc. recently announced it has completed its acquisition of Tower Holdings, Inc. (including operating subsidiaries CorePharma LLC and Amedra Pharmaceuticals LLC), and Lineage…
US Asthma Treatment Market Value to Hit $14 Billion
The US treatment market for asthma will rise in value from $11.7 billion in 2013 to an estimated $14 billion by 2020, representing a Compound…
AgeneBio Announces Phase II Clinical Trial Results
AgeneBio recently announced the publication of complete Phase II clinical trial results in NeuroImage: Clinical for its lead product candidate. The results show that AGB101…
Allergen Research Corporation Completes $80-Million Financing to Advance Drug Development Portfolio
Allergen Research Corporation (ARC) recently announced the completion of an $80- million Series B financing. Foresite Capital led the round, with participation from existing investor…
Xcelience to Expand Operations, Will Create 100 New Jobs, Capital Investment of More Than $9 Million
TAMPA, Fla. – March 13, 2014 - Today, Governor Rick Scott announced the expansion of Xcelience, an international contract development and manufacturing organization (CDMO) servicing…
Opportunities Galore in Biosimilars Industry
BCC Research reveals in its new report on biosimilars, the development of biotherapeutics through the use of advanced technology has facilitated the management of disease…
Stents Market to Reach More Than $10.6 Billion in 2019
BCC Research reveals in its new report on stents there has recently been several innovations and developments expected to influence the market, particularly with bioabsorbable…
Combination Product Technology to Reach $31 Billion; Sector Attracting Massive Developmental Companies
BCC Research reveals in its new report on drug-device combination products, developments in cell-based therapeutics, progenitor cell exploitation, growth factor delivery, and advanced formulation strategies…
Patheon Adds Complex Solubility Expertise With Acquisition of Agere
Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, has reached a definitive agreement to acquire…
ModiQuest Research & Cellectis to Collaborate on Antibody Generation for Potential CAR Development
ModiQuest Research BV, the Dutch antibody services company, recently announced that it has entered into a collaboration with Cellectis aimed at the generation of novel…
Macrolide Pharmaceuticals Launches With $22-Million Financing
Macrolide Pharmaceuticals, a new company with groundbreaking technology to develop novel antibiotics, completed a Series A financing of $22 million led by Novartis Venture Fund,…
PlasmaTech Biopharmaceuticals Announces Initiation of Enrollment of MuGard Trial
PlasmaTech Biopharmaceuticals, Inc. recently announced that enrollment has begun in a clinical trial at UCLA's Jonsson Comprehensive Cancer Center that is evaluating MuGard in the…
AbbVie Acquires Pharmacyclics to Help Secure Future Cash Flows as Humira Biosimilars Loom
“AbbVie’s acquisition of Pharmacyclics (PCYC), valued at $21 billion, will help the company alleviate its dependency on Humira, which accounted for 62% of its total…
Domain Therapeutics Launches Specific Purpose Vehicle Kaldi Pharma
Domain Therapeutics recently announced the creation of a Specific Purpose Vehicle (SPV), Kaldi Pharma, for the exclusive development of its A2a/A1 and A2a antagonist programs.…
Bristol-Myers Squibb Signs Exclusive Agreement with Bavarian Nordic
Bavarian Nordic and Bristol-Myers Squibb Company recently announced an agreement that provides Bristol-Myers Squibb an exclusive option to license and commercialize PROSTVAC, Bavarian Nordic's investigational…
Patheon Expands Comprehensive API Services With Major Acquisition
Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, recently announced it has reached a definitive…
Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments
Although lung cancer is the third most prevalent cancer type in the world, there are only 18 drugs in the market for its treatment. Further,…
Victrex Launches Multi-Million Dollar Investment in Technology Innovation
Victrex plc, a UK-based global world leader in high-performance polyaryletherketone (PAEK) polymers is planning to increase its global technology leadership with the construction of a…
New Drug Company to Focus on Treating Unmet Medical Needs Across Broad Therapeutic Areas
Turing Pharmaceuticals AG recently announced its official launch, along with news of three acquisitions for its commercial operations and development pipeline. The company also introduced…
XstalBio Issued US Patent for Stabilization of Therapeutic Proteins
XstalBio Ltd a biologic formulation and drug delivery company recently announced the United States Patent and Trademark Office has issued US Patent, US 8,932,715, covering…
